Ascendis Pharma A-S
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $344,902 | $250,656 | $245,179 | $213,634 |
Gross Profit | 312,605 | 229,031 | 217,981 | 191,280 |
EBITDA | 68,075 | 23,681 | 39,722 | -53,353 |
EBIT | 63,431 | 19,391 | 34,944 | -57,372 |
Net Income | 210,396 | 639,688 | -33,247 | -60,989 |
Net Change In Cash | 344,902 | 250,656 | 245,179 | 213,634 |
Free Cash Flow | 283,109 | -15,686 | 67,373 | 2,100 |
Cash | 811,924 | 573,417 | 615,778 | 539,092 |
Basic Shares | 68,320 | 64,521 | 61,380 | 60,989 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $691,710 | $363,641 | $266,718 | $51,174 |
Gross Profit | 588,530 | 319,383 | 222,323 | 39,037 |
EBITDA | -109,796 | -290,023 | -411,168 | -529,177 |
EBIT | -126,794 | -307,737 | -430,079 | -546,691 |
Net Income | -219,034 | -378,084 | -481,447 | -583,194 |
Net Change In Cash | 691,710 | 363,641 | 266,718 | 51,174 |
Free Cash Flow | 43,619 | -307,624 | -469,803 | -510,188 |
Cash | 615,778 | 559,543 | 392,164 | 444,767 |
Basic Shares | 60,607 | 57,891 | 56,287 | 56,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $3.29 |
2026-03-31 | $0.27 |
2025-12-31 | -$0.55 |
2025-09-30 | -$1 |